KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Tax Rate (2016 - 2025)

Historic Tax Rate for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 6.48%.

  • Pfizer's Tax Rate fell 114400.0% to 6.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 100800.0%. This contributed to the annual value of 0.35% for FY2024, which is 1050400.0% up from last year.
  • Latest data reveals that Pfizer reported Tax Rate of 6.48% as of Q3 2025, which was down 114400.0% from 4.63% recorded in Q2 2025.
  • In the past 5 years, Pfizer's Tax Rate ranged from a high of 130.1% in Q2 2024 and a low of 6.79% during Q1 2025
  • For the 5-year period, Pfizer's Tax Rate averaged around 15.5%, with its median value being 9.98% (2024).
  • As far as peak fluctuations go, Pfizer's Tax Rate soared by 1332300bps in 2024, and later crashed by -1254700bps in 2025.
  • Pfizer's Tax Rate (Quarter) stood at 4.18% in 2021, then skyrocketed by 195bps to 3.96% in 2022, then soared by 387bps to 19.25% in 2023, then tumbled by -74bps to 4.96% in 2024, then tumbled by -231bps to 6.48% in 2025.
  • Its last three reported values are 6.48% in Q3 2025, 4.63% for Q2 2025, and 6.79% during Q1 2025.